These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 23170982)
41. Functional consequences of hypertrophic and dilated cardiomyopathy-causing mutations in alpha-tropomyosin. Chang AN; Harada K; Ackerman MJ; Potter JD J Biol Chem; 2005 Oct; 280(40):34343-9. PubMed ID: 16043485 [TBL] [Abstract][Full Text] [Related]
42. Expression of smooth muscle and nonmuscle tropomyosins in Escherichia coli and characterization of bacterially produced tropomyosins. Novy RE; Liu LF; Lin CS; Helfman DM; Lin JJ Biochim Biophys Acta; 1993 Mar; 1162(3):255-65. PubMed ID: 8457589 [TBL] [Abstract][Full Text] [Related]
43. Alteration of tropomyosin-binding properties of tropomodulin-1 affects its capping ability and localization in skeletal myocytes. Moroz NA; Novak SM; Azevedo R; Colpan M; Uversky VN; Gregorio CC; Kostyukova AS J Biol Chem; 2013 Feb; 288(7):4899-907. PubMed ID: 23271735 [TBL] [Abstract][Full Text] [Related]
44. Dimerization of tropomyosins. Gimona M Adv Exp Med Biol; 2008; 644():73-84. PubMed ID: 19209814 [TBL] [Abstract][Full Text] [Related]
45. Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy. Ryba DM; Warren CM; Karam CN; Davis RT; Chowdhury SAK; Alvarez MG; McCann M; Liew CW; Wieczorek DF; Varga P; Solaro RJ; Wolska BM Circ Heart Fail; 2019 Nov; 12(11):e005835. PubMed ID: 31684756 [TBL] [Abstract][Full Text] [Related]
46. Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant alpha-tropomyosins in adult cardiac myocytes. Michele DE; Albayya FP; Metzger JM Nat Med; 1999 Dec; 5(12):1413-7. PubMed ID: 10581085 [TBL] [Abstract][Full Text] [Related]
47. N-terminal modification and its effect on the biochemical characteristics of Akazara scallop tropomyosins expressed in Escherichia coli. Inoue A; Ojima T; Nishita K J Biochem; 2004 Jul; 136(1):107-14. PubMed ID: 15269246 [TBL] [Abstract][Full Text] [Related]
49. Structure and tropomyosin binding properties of the N-terminal capping domain of tropomodulin 1. Greenfield NJ; Kostyukova AS; Hitchcock-DeGregori SE Biophys J; 2005 Jan; 88(1):372-83. PubMed ID: 15475586 [TBL] [Abstract][Full Text] [Related]
50. Independent functions for the N- and C-termini in the overlap region of tropomyosin. Moraczewska J; Hitchcock-DeGregori SE Biochemistry; 2000 Jun; 39(23):6891-7. PubMed ID: 10841770 [TBL] [Abstract][Full Text] [Related]
51. Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathies. Michele DE; Metzger JM J Mol Med (Berl); 2000; 78(10):543-53. PubMed ID: 11199327 [TBL] [Abstract][Full Text] [Related]
52. Functional homodimers and heterodimers of recombinant smooth muscle tropomyosin. Coulton A; Lehrer SS; Geeves MA Biochemistry; 2006 Oct; 45(42):12853-8. PubMed ID: 17042503 [TBL] [Abstract][Full Text] [Related]
53. Mutations Q93H and E97K in Śliwinska M; Robaszkiewicz K; Wasąg P; Moraczewska J Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919826 [TBL] [Abstract][Full Text] [Related]
54. Vertebrate tropomyosin: distribution, properties and function. Perry SV J Muscle Res Cell Motil; 2001; 22(1):5-49. PubMed ID: 11563548 [TBL] [Abstract][Full Text] [Related]
55. Folding and stability of a coiled-coil investigated using chemical and physical denaturing agents: comparative analysis of polymerized and non-polymerized forms of alpha-tropomyosin. Morais AC; Ferreira ST Int J Biochem Cell Biol; 2005 Jul; 37(7):1386-95. PubMed ID: 15833271 [TBL] [Abstract][Full Text] [Related]
56. The stability of tropomyosin, a two-stranded coiled-coil protein, is primarily a function of the hydrophobicity of residues at the helix-helix interface. Greenfield NJ; Hitchcock-DeGregori SE Biochemistry; 1995 Dec; 34(51):16797-805. PubMed ID: 8527455 [TBL] [Abstract][Full Text] [Related]
57. The effects of cardiomyopathy-associated mutations in the head-to-tail overlap junction of α-tropomyosin on its properties and interaction with actin. Matyushenko AM; Koubassova NA; Shchepkin DV; Kopylova GV; Nabiev SR; Nikitina LV; Bershitsky SY; Levitsky DI; Tsaturyan AK Int J Biol Macromol; 2019 Mar; 125():1266-1274. PubMed ID: 30240712 [TBL] [Abstract][Full Text] [Related]
58. The effect of the Asp175Asn and Glu180Gly TPM1 mutations on actin-myosin interaction during the ATPase cycle. Rysev NA; Karpicheva OE; Redwood CS; Borovikov YS Biochim Biophys Acta; 2012 Feb; 1824(2):366-73. PubMed ID: 22155441 [TBL] [Abstract][Full Text] [Related]
59. Folding and function of the troponin tail domain. Effects of cardiomyopathic troponin T mutations. Hinkle A; Tobacman LS J Biol Chem; 2003 Jan; 278(1):506-13. PubMed ID: 12409295 [TBL] [Abstract][Full Text] [Related]
60. A peek into tropomyosin binding and unfolding on the actin filament. Singh A; Hitchcock-Degregori SE PLoS One; 2009 Jul; 4(7):e6336. PubMed ID: 19629180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]